|
Dr. Sherman joins IDM Pharma from Takeda Global Research & Development Center Inc. a subsidiary of Takeda Pharmaceutical Company Limited where he served as Vice President of Clinical Science Oncology. Prior to Takeda Dr. Sherman served as Chief Medical Officer and Executive Vice President at NeoPharm Inc. where he was responsible for developing clinical drug research and development strategies.
Before joining NeoPharm Dr. Sherman held various roles at Searle/Pharmacia Research and Development and Medical Marketing including Executive Director of Clinical Research and Head of Oncology Medical Operations. In these roles he managed clinical development activities for a variety of therapeutic areas including oncology infectious diseases women's health sleep and central nervous system. Prior to Searle/Pharmacia Dr. Sherman was at Squibb/Bristol-Myers Squibb in Clinical Pharmacology and Clinical Research.
Dr. Sherman received his medical degree from the Rosalind Franklin University/Chicago Medical School. He completed both an internship and residency in internal medicine at the Northwestern University McGaw Medical Center where he also served as a chief medical resident. In addition Dr. Sherman completed fellowship training at the University of California San Francisco (UCSF) and also served as a research associate at the Howard Hughes Medical Institute at UCSF. Dr. Sherman is currently a Board Member of the Drug Information Association (DIA) and will be chairing the DIA 2008 Annual Meeting. | 